ICFs, Assent & Short Forms for Oncology, Rare Disease and High-Risk Therapeutic Areas
ICFs, Assent & Short Forms for Oncology, Rare Disease and High-Risk Therapeutic Areas ICFs, Assent & Short Forms for Oncology, Rare Disease and High-Risk Therapeutic Areas In the context of clinical trials, informed consent forms (ICFs), assent, and short forms play a critical role in ensuring the ethical conduct of research and the protection of…
Read More “ICFs, Assent & Short Forms for Oncology, Rare Disease and High-Risk Therapeutic Areas” »